Hyperparathyroidism

Last updated: November 01, 2022

Hyperparathyroidism

Watch later

Watch later

Multiple endocrine neoplasia
Seronegative and septic arthritis: Pathology review
Primary sclerosing cholangitis
Papulosquamous and inflammatory skin disorders: Pathology review
Bleeding disorders: Clinical
Nephritic and nephrotic syndromes: Clinical
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Aortic dissections and aneurysms: Pathology review
Reactive arthritis
Seronegative arthritis: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Rheumatoid arthritis: Clinical
Systemic lupus erythematosus (SLE): Pathology review
MEN syndromes: Clinical
Leg ulcers: Clinical
Breast cancer: Pathology review
Parkinson disease
Non-Hodgkin lymphoma
Lymphomas: Pathology review
Lymphoma: Clinical
Cushing syndrome
Cushing syndrome: Clinical
Cushing syndrome and Cushing disease: Pathology review
Cirrhosis: Clinical
Physiological changes during exercise
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Thrombotic thrombocytopenic purpura
Thrombocytopenia: Clinical
Hemophilia
Coagulation disorders: Pathology review
Chronic leukemia
Anemia of chronic disease
Peripheral artery disease: Pathology review
Peripheral vascular disease: Clinical
Dermatomyositis
Myalgias and myositis: Pathology review
Hypocalcemia
Hypercalcemia
Hypokalemia
Hypernatremia
Hypernatremia: Clinical
Hyponatremia: Clinical
Hypokalemia: Clinical
Hypomagnesemia
Miscellaneous hypoglycemics
Insulins
Renal artery stenosis
Antiplatelet medications
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Acneiform skin disorders: Pathology review
Staphylococcus aureus
Streptococcus pyogenes (Group A Strep)
Herpes simplex virus
Chronic kidney disease
Vitamin B12 deficiency
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Goodpasture syndrome
Myelodysplastic syndromes
Sjogren syndrome
Sjogren syndrome: Pathology review
Sjogren syndrome: Clinical
Psoriasis
Crohn disease
Acute pyelonephritis
Chronic pyelonephritis
Hypoglycemics: Insulin secretagogues
Gout
Gout and pseudogout: Pathology review
Ulcerative colitis
Inflammatory bowel disease: Clinical
Celiac disease
DNA alkylating medications
Chronic kidney disease: Clinical
Hidradenitis suppurativa
ACE inhibitors, ARBs and direct renin inhibitors
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Bone tumors
Pediatric bone tumors: Clinical
Bone tumors: Pathology review
Developmental dysplasia of the hip
Venous thromboembolism: Clinical
Carpal tunnel syndrome
Heart failure
Thiazide and thiazide-like diuretics
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Positive inotropic medications
Hyperthyroidism
Hyperthyroidism: Pathology review
Lichen planus
Viral hepatitis: Clinical
Hepatitis medications
Viral hepatitis: Pathology review
Autoimmune hepatitis
Pleural effusion: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Rotator cuff tear
Anatomy clinical correlates: Clavicle and shoulder
Breast cancer: Clinical
Osteomalacia and rickets
Pelvic inflammatory disease
Mastocytosis (NORD)
Hernias: Clinical
Abdominal hernias
von Hippel-Lindau disease
PDE5 inhibitors
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Pemphigus vulgaris
Polycystic ovary syndrome
Miscellaneous lipid-lowering medications
Monoclonal antibodies
Osteoarthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Cytokines
Glucocorticoids
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Platelet disorders: Pathology review
Deep vein thrombosis
Pulmonary embolism
Thrombophlebitis
Opioid agonists, mixed agonist-antagonists and partial agonists
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Heparin
Heparin-induced thrombocytopenia
Peripheral artery disease
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Membranous nephropathy
Poststreptococcal glomerulonephritis
IgA nephropathy (NORD)
Membranoproliferative glomerulonephritis
Rapidly progressive glomerulonephritis
Anticonvulsants and anxiolytics: Benzodiazepines
Diverticulosis and diverticulitis
Sarcoidosis
Acute leukemia
Vasculitis
Primary biliary cholangitis
Hyperkalemia
Jaundice
Stevens-Johnson syndrome
Osteoporosis medications
General anesthetics
Selective serotonin reuptake inhibitors
Systemic lupus erythematosus (SLE): Clinical
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Diabetes insipidus and SIADH: Pathology review
Hepatic encephalopathy
Osteomyelitis
Fibromyalgia
Cell-mediated immunity of natural killer and CD8 cells
Ankylosing spondylitis
Septic arthritis
Hyperparathyroidism
Parathyroid conditions and calcium imbalance: Clinical
Heart failure: Clinical
Cardiomyopathies: Pathology review
Cardiomyopathies: Clinical
Gastrointestinal bleeding: Pathology review
Acute pancreatitis
Pancreatitis: Clinical
Pancreatitis: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastroesophageal reflux disease (GERD)
Peptic ulcers and stomach cancer: Clinical
Gastric cancer
Colorectal polyps
Colorectal cancer
Colorectal polyps and cancer: Pathology review
Colorectal cancer: Clinical
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Pediatric infectious rashes: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
Phosphate, calcium and magnesium homeostasis
Obstructive lung diseases: Pathology review
Fever of unknown origin: Clinical
Malabsorption: Clinical
Neurocutaneous disorders: Pathology review
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Acute kidney injury: Clinical
Neisseria gonorrhoeae
Non-urothelial bladder cancers
Alopecia: Clinical
Esophageal disorders: Clinical
Esophageal disorders: Pathology review
Esophageal surgical conditions: Clinical
Peptic ulcer
Porphyria cutanea tarda
Acute intermittent porphyria
Myocardial infarction
Hypopigmentation skin disorders: Clinical
Subdural hematoma
Alport syndrome
Bullous pemphigoid
Thyroid nodules and thyroid cancer: Clinical
Pheochromocytoma
Kidney stones: Clinical
Asthma: Clinical
Pneumonia: Pathology review
Pneumonia: Clinical
Diarrhea: Clinical
Jaundice: Pathology review
Restrictive lung diseases: Pathology review
Renal failure: Pathology review

Transcript

Watch video only

With hyperparathyroidism, “hyper” refers to over, and “parathyroid” refers to the parathyroid glands, so hyperparathyroidism refers to a condition where there is an overproduction of parathyroid hormone.

Parathyroid hormone comes from the parathyroid glands which are buried within the thyroid gland, and their main job is to keep blood calcium levels stable.

Now, the majority of the extracellular calcium, the calcium in the blood and interstitium, is split almost equally between two groups - calcium that is diffusible and calcium that is not diffusible.

Diffusible calcium is small enough to diffuse across cell membranes and is separated into two subcategories.

The first is free-ionized calcium, which is involved in all sorts of cellular processes like neuronal action potentials, contraction of skeletal, smooth, and cardiac muscle, hormone secretion, and blood coagulation, all of which are tightly regulated by enzymes and hormones.

The second category is complexed calcium, which is where the positively charged calcium is ionically linked to tiny negatively charged molecules like oxalate, which is a small anion that are normally found in our blood in small amounts.

The complexed calcium forms a molecule that’s electrically neutral but unlike free-ionized calcium it’s not useful for cellular processes.

Both of these are called diffusible because they’re small enough to diffuse across cell membranes.

Finally there’s the non-diffusible calcium which is bound to negatively charged proteins like albumin.

The resulting protein-calcium complex is too large and charged to cross membranes, leaving this calcium also uninvolved in cellular processes.

Changes in the body’s levels of extracellular calcium are detected by a surface receptor in parathyroid cells that’s called the calcium-sensing receptor.

These changes affect the amount of parathyroid hormone that’s released by the parathyroid gland.

The parathyroid hormone gets the bones to release calcium, it gets the kidneys to reabsorb more calcium so it's not lost in the urine, and it synthesizes calcitriol, which is also known as 1,25-dihydroxycholecalciferol, or active vitamin D.

Active vitamin D then goes on to cause the gastrointestinal tract to increase calcium absorption.

Altogether, these effects help to keep the extracellular levels of calcium within a narrow range that’s between 8.5 to 10 mg/dl.

So there are three types of hyperparathyroidism - primary, secondary, and tertiary.

In primary hyperparathyroidism, the parathyroid gland is responsible for the problem, because it makes parathyroid hormone independently of the calcium level.

Excess parathyroid hormone stimulates osteoclasts to break down bone and makes the kidneys hold on to calcium and get rid of phosphate - resulting in hypercalcemia and hypophosphatemia.

The excess calcium makes neurons less excitable, which leads to slower muscle contractions, and diminishes neuron firing in the central nervous system.

It also causes hypercalciuria - excess loss of calcium in urine - which can lead to dehydration. This is because there is just too much calcium to be reabsorbed by the kidneys.

Most often, primary hyperparathyroidism is caused by a single parathyroid adenoma, or benign tumor, which happens either because of a genetic mutation in a single cell or because of an inherited disorder like multiple endocrine neoplasia, which affects the parathyroid, pancreas, and pituitary glands.

Rarely, primary hyperparathyroidism is caused by hyperplasia, where parathyroid cells divide excessively causing growth of the glands, or by a parathyroid carcinoma, a cancerous tumor.

In secondary hyperparathyroidism, the parathyroid gland is normal, but it makes excess parathyroid hormone in response to chronic hypocalcemia - a low level of calcium - from another cause.

Key Takeaways

Hyperparathyroidism is a condition in which the parathyroid glands produce too much parathyroid hormone (PTH), which regulates calcium levels in the blood. Hyperparathyroidism can be primary, secondary, or even tertiary.

Primary hyperparathyroidism usually results from PTH secretion by a parathyroid adenoma. It is characterized by excess PTH that leads to high blood calcium levels (hypercalcemia), bone mass loss, kidney stones, and other health problems, such as psychiatric issues.

Secondary hyperparathyroidism develops when there are conditions like chronic kidney disease, which can lead to low calcium, high phosphate, and low vitamin D levels. It is mainly characterized by osteodystrophy, in which there is bone weakening associated with bone pain and deformation.

Finally, there is tertiary hyperparathyroidism, which occurs because of chronic secondary hyperparathyroidism from kidney disease. This leads to hypercalcemia and phosphate imbalances.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Harrison's Endocrinology, 4E" McGraw-Hill Education / Medical (2016)
  6. "Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications" Endocrine Reviews (2001)
  7. "Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients" Cochrane Database of Systematic Reviews (2014)